165 related articles for article (PubMed ID: 416892)
1. The TRH test: its value in the diagnosis of Graves' ophthalmopathy.
Jackson WB; Tolis G; Chertman M
Can J Ophthalmol; 1978 Jan; 13(1):10-4. PubMed ID: 416892
[TBL] [Abstract][Full Text] [Related]
2. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
3. Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients.
Tamai H; Ohsako N; Takeno K; Fukino O; Takahashi H; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1980 Nov; 51(5):1123-7. PubMed ID: 6774999
[TBL] [Abstract][Full Text] [Related]
4. Ophthalmic Graves' disease.
Mornex R; Fournier G; Berthezene F
Mod Probl Ophthalmol; 1975; 14():426-31. PubMed ID: 1242209
[TBL] [Abstract][Full Text] [Related]
5. Graves' ophthalmopathy and subclinical hypothyroidism: diagnostic value of the thyrotropin releasing hormone test.
Walfish PG; Gottesman IS; Baxter JL
Can Med Assoc J; 1982 Aug; 127(4):291-4. PubMed ID: 6807523
[TBL] [Abstract][Full Text] [Related]
6. Graves' orbitopathy and the thyrotropin-releasing hormone (TRH) test.
Rush JA; Older JJ
J Clin Neuroophthalmol; 1981 Sep; 1(3):219-24. PubMed ID: 6213665
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the TRH test on the patients with Graves' disease during the treatment with antithyroid drug (author's transl)].
Enomoto K; Inoue K; Enomoto H
Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):1052-64. PubMed ID: 823053
[TBL] [Abstract][Full Text] [Related]
8. [Discrepancies between TRH test and classical dynamic thyroid tests results in hyperthyroidism. 47 cases (author's transl)].
Doumith R; Simon D; Bruet A; Vallée G
Nouv Presse Med; 1979 Oct; 8(41):3319-23. PubMed ID: 118429
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of T3 suppression and TRH stimulation tests in the diagnosis of ophthalmic Graves' disease].
Tao Y; Song GX
Zhonghua Yi Xue Za Zhi; 1987 Dec; 67(12):665-7. PubMed ID: 3130158
[No Abstract] [Full Text] [Related]
10. Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
Kashiwai T; Tada H; Watanabe Y; Shimaoka Y; Yagoro A; Hidaka Y; Fujikado T; Amino N
Thyroid; 1998 Oct; 8(10):881-5. PubMed ID: 9827654
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
[TBL] [Abstract][Full Text] [Related]
12. [Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmopathy].
Wenzel KW
Endokrinologie; 1975 Sep; 66(1):67-73. PubMed ID: 1243821
[TBL] [Abstract][Full Text] [Related]
13. A study of thyroid function after subtotal thyroidectomy for Graves' disease: particularly on TRH tests, T3 suppression tests and antithyroid antibodies in euthyroid patients.
Fukino O; Tamai H; Fujii S; Ohsako N; Matsubayashi S; Kuma K; Nagataki S
Acta Endocrinol (Copenh); 1983 May; 103(1):28-33. PubMed ID: 6407253
[TBL] [Abstract][Full Text] [Related]
14. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
Wiersinga WM; Smit T; van der Gaag R; Koornneef L
J Endocrinol Invest; 1988 Sep; 11(8):615-9. PubMed ID: 2907524
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-releasing hormone (a test to diagnose Graves' ophthalmopathy).
Hyman BN; Johnson PC
Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(3 Pt 2):OP524-8. PubMed ID: 50663
[No Abstract] [Full Text] [Related]
16. [Experience with the thyrotropin releasing hormone (TRH) test in the diagnosis of Graves' ophthalmopathy].
Otter R; Wiersinga WM; Peeters HF; Bleeker GM; Touber JL
Ned Tijdschr Geneeskd; 1982 Nov; 126(48):2189-93. PubMed ID: 6817147
[No Abstract] [Full Text] [Related]
17. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM; Schimmel M; Utiger RD
J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
[TBL] [Abstract][Full Text] [Related]
18. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
[TBL] [Abstract][Full Text] [Related]
19. Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease.
Tamai H; Suematsu H; Ikemi Y; Kuma K; Matsuzuka F; Kumagai LF; Shizume K; Nagataki S
J Clin Endocrinol Metab; 1978 Sep; 47(3):475-9. PubMed ID: 122407
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormones homeostasis and TSH in autonomic thyroid nodule.
Negoescu I; Simescu M; Constantinescu A
Endocrinologie; 1978; 16(2):111-6. PubMed ID: 79214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
